A Potential Target for Diabetic Vascular Damage: High Glucose-Induced Monocyte Extracellular Vesicles Impair Endothelial Cells by Delivering miR-142-5p
Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial...
Saved in:
Published in | Frontiers in bioengineering and biotechnology Vol. 10; p. 913791 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
09.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells (
HG-
THP-1 EVs and
BG-
THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT–qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to
BG-
THP-1 EVs,
HG-
THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation.
HG-
THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT–qPCR results showed that
HG-
THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on
HG-
THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection. |
---|---|
AbstractList | Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells (HG-THP-1 EVs and BG-THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT–qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to BG-THP-1 EVs, HG-THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. HG-THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT–qPCR results showed that HG-THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on HG-THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection. Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells (HG-THP-1 EVs and BG-THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT-qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to BG-THP-1 EVs, HG-THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. HG-THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT-qPCR results showed that HG-THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on HG-THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection.Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells (HG-THP-1 EVs and BG-THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT-qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to BG-THP-1 EVs, HG-THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. HG-THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT-qPCR results showed that HG-THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on HG-THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection. Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells ( HG- THP-1 EVs and BG- THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT–qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to BG- THP-1 EVs, HG- THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. HG- THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT–qPCR results showed that HG- THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on HG- THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection. Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the innate immune system is growing. We tested whether EVs derived from high glucose-induced monocytes could shuttle microRNAs and impair endothelial cells. EVs from high glucose- and basal glucose-treated THP-1 cells ( THP-1 EVs and THP-1 EVs) were isolated and identified. After coculture with THP-1 EVs, human umbilical vein endothelial cells (HUVECs) were tested by proliferation, migration, reactive oxygen species (ROS) detection assays, and western blot for Nrf2/NLRP3 signaling. MiR-142-5p was predicted by miRNAs databases and further verified by RT-qPCR and dual-luciferase reporter gene assays that inhibit Nrf2 expression. The regulation of miR-142-5p in HUVECs was further evaluated. A type 1 diabetes mellitus (T1DM) mouse model was developed for miR-142-5p inhibition. Aorta tissue was harvested for hematoxylin-eosin staining and immunohistochemistry of interleukin-1β (IL-1β). Compared to THP-1 EVs, THP-1 EVs significantly reduced migration and increased ROS production in HUVECs but did not affect proliferation. THP-1 EVs induced suppression of Nrf2 signaling and NLRP3 signaling activation. RT-qPCR results showed that THP-1 EVs overexpressed miR-142-5p in HUVECs. The transfection of miR-142-5p mimics into HUVECs exhibited consistent regulatory effects on THP-1 EVs, whereas miR-142-5p inhibitors demonstrated protective effects. The miR-142-5p antagomir significantly reduced the IL-1β level in T1DM aortas despite morphological changes. To conclude, miR-142-5p transferred by high glucose-induced monocyte EVs participates in diabetic endothelial damage. The inhibition of miR-142-5p could be a potential adjuvant to diabetic cardiovascular protection. |
Author | Niu, Shuai Rong, Zhihua Li, Fengshi Liu, Changwei Ni, Leng Di, Xiao Zhang, Rui |
AuthorAffiliation | Department of Vascular Surgery , Peking Union Medical College Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China |
AuthorAffiliation_xml | – name: Department of Vascular Surgery , Peking Union Medical College Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China |
Author_xml | – sequence: 1 givenname: Rui surname: Zhang fullname: Zhang, Rui – sequence: 2 givenname: Shuai surname: Niu fullname: Niu, Shuai – sequence: 3 givenname: Zhihua surname: Rong fullname: Rong, Zhihua – sequence: 4 givenname: Fengshi surname: Li fullname: Li, Fengshi – sequence: 5 givenname: Leng surname: Ni fullname: Ni, Leng – sequence: 6 givenname: Xiao surname: Di fullname: Di, Xiao – sequence: 7 givenname: Changwei surname: Liu fullname: Liu, Changwei |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35615474$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ksFu1DAQhiNUREvpA3BBPnLJYjtxHHNAqrZLu1IRCJVerYkzybpK4sV2KvZJeF2S3Ra1SJxsj__5fnn8v06OBjdgkrxldJFlpfrQVNbhglPOF4plUrEXyQnnqkhzVoqjJ_vj5CyEO0op40KKkr9KjjNRMJHL_CT5fU6-uYhDtNCRG_AtRtI4Ty4sVBitIbcQzNjBVIEeWvxIrmy7IZfdaFzAdD3Uo8GafHGDM7uIZPUrejDYdfueWwzWdBjIut-C9WQ11C5usJvNlpMokGpHLqbzPXo7tKS331OW81Rs3yQvG-gCnj2sp8mPz6ub5VV6_fVyvTy_Tk1eiJgyqJSouEBW01opXpgGGQPBm8aojFdQUw5McabqAoU0ikmGIIFlNTVllmenyfrArR3c6a23PfiddmD1vuB8q8HH-RF68hI0M1IWYHKJEqDgSBmVTV0qVqmJ9enA2o5Vj7WZpuqhewZ9fjPYjW7dvVaM52VZToD3DwDvfo4You5tmIcJA7oxaF5ISgtBmZik7556_TV5_NlJIA8C410IHhttbIRo3WxtO82onmOk9zHSc4z0IUZTJ_un8xH-_54_KhrNCA |
CitedBy_id | crossref_primary_10_3390_ijms26031008 crossref_primary_10_1186_s12933_023_01965_7 crossref_primary_10_1038_s42255_023_00971_z crossref_primary_10_3390_ijms25020934 crossref_primary_10_53469_jcmp_2024_06_09__08 crossref_primary_10_1038_s41392_023_01333_7 crossref_primary_10_1007_s12026_024_09462_z |
Cites_doi | 10.1186/s12933-017-0513-y 10.3389/fimmu.2021.682948 10.1002/biof.1395 10.3390/antiox10081306 10.1155/2013/879516 10.1042/CS20180905 10.3390/antiox10091463 10.3892/ijmm.2021.5020 10.1016/j.phrs.2021.105868 10.3727/096504016X14719078133366 10.1177/2058738420909041 10.3389/fcell.2022.824165 10.1016/j.atherosclerosis.2010.01.035 10.3892/mmr.2015.3191 10.1007/s11010-017-3256-x 10.1186/1471-2105-15-293 10.1161/CIRCRESAHA.118.314601 10.1016/j.bbrc.2021.02.070 10.1016/s0092-8674(04)00045-5 10.1186/s12872-021-01893-y 10.1093/nar/gkx1141 10.14336/AD.2021.0708 10.1186/s13059-019-1629-z 10.3389/fcvm.2021.733985 10.1016/j.bbrc.2021.08.053 10.1016/j.imbio.2019.02.004 10.3390/cells10102663 10.3389/fphys.2018.01857 10.1093/eurheartj/ehx581 10.18632/aging.202829 10.1038/ng1536 10.1101/gr.082701.108 10.1007/s12011-021-02773-4 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu. Copyright © 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu. 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu |
Copyright_xml | – notice: Copyright © 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu. – notice: Copyright © 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu. 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fbioe.2022.913791 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
DocumentTitleAlternate | Zhang et al |
EISSN | 2296-4185 |
ExternalDocumentID | oai_doaj_org_article_1ab503c776ac47e7aa62e0107fd891b9 PMC9124888 35615474 10_3389_fbioe_2022_913791 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAYXX ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RPM IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c465t-1ab95b25e1d0d9926cfe11a52ffc932bad02a19219d6e57c9171ea7a13d0c8343 |
IEDL.DBID | M48 |
ISSN | 2296-4185 |
IngestDate | Wed Aug 27 01:17:43 EDT 2025 Thu Aug 21 18:19:16 EDT 2025 Fri Jul 11 16:28:01 EDT 2025 Thu Apr 03 06:56:30 EDT 2025 Thu Apr 24 23:06:46 EDT 2025 Tue Jul 01 02:45:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | miR-142-5p monocytes diabetes mellitus extracellular vesicles endothelial damage |
Language | English |
License | Copyright © 2022 Zhang, Niu, Rong, Li, Ni, Di and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c465t-1ab95b25e1d0d9926cfe11a52ffc932bad02a19219d6e57c9171ea7a13d0c8343 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Biomaterials, a section of the journal Frontiers in Bioengineering and Biotechnology Reviewed by: Shucong Li, Massachusetts Institute of Technology, United States Huayi Wang, Chinese Institute for Brain Research, Beijing (CIBR), China Edited by: Xiaoguang Wang, The Ohio State University, United States |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fbioe.2022.913791 |
PMID | 35615474 |
PQID | 2670065015 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1ab503c776ac47e7aa62e0107fd891b9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9124888 proquest_miscellaneous_2670065015 pubmed_primary_35615474 crossref_citationtrail_10_3389_fbioe_2022_913791 crossref_primary_10_3389_fbioe_2022_913791 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-05-09 |
PublicationDateYYYYMMDD | 2022-05-09 |
PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-09 day: 09 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in bioengineering and biotechnology |
PublicationTitleAlternate | Front Bioeng Biotechnol |
PublicationYear | 2022 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Liu (B15) 2018; 445 Krek (B14) 2005; 37 Lou (B18) 2017; 25 Miao (B20) 2013; 2013 Zhao (B32); 173 Karagkouni (B13) 2018; 46 Sáez (B23) 2019; 224 Liu (B17) 2020; 34 Hu (B9) 2018; 44 Maruhashi (B19) 2021; 10 Hoogeveen (B7) 2018; 39 Xu (B31) 2015; 11 Jin (B11) 2021; 48 Abd El-Khalik (B1) 2021; 200 Hur (B10) 2010; 211 Alonso-Piñeiro (B2) 2021; 10 Friedman (B5) 2009; 19 Bartel (B4) 2004; 116 Teodoro (B27) 2018; 9 Zhao (B33); 13 Bardou (B3) 2014; 15 Jurgielewicz (B12) 2021; 12 Sanwlani (B24) 2021; 10 Puhm (B22) 2019; 125 Thiem (B28) 2019; 133 Grieco (B6) 2021; 12 Liu (B16) 2019; 20 Wang (B29) 2021; 548 Xu (B30) 2021; 8 Pan (B21) 2021; 21 Sharma (B25) 2017; 16 Hu (B8) 2021; 575 Song (B26) 2022; 10 |
References_xml | – volume: 16 start-page: 33 year: 2017 ident: B25 article-title: The Nuclear Factor (Erythroid-derived 2)-like 2 (Nrf2) Activator Dh404 Protects against Diabetes-Induced Endothelial Dysfunction publication-title: Cardiovasc Diabetol. doi: 10.1186/s12933-017-0513-y – volume: 12 start-page: 682948 year: 2021 ident: B6 article-title: Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-To-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.682948 – volume: 44 start-page: 123 year: 2018 ident: B9 article-title: Dihydromyricetin Inhibits NLRP3 Inflammasome-dependent Pyroptosis by Activating the Nrf2 Signaling Pathway in Vascular Endothelial Cells publication-title: Biofactors doi: 10.1002/biof.1395 – volume: 10 start-page: 1306 year: 2021 ident: B19 article-title: Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction publication-title: Antioxidants doi: 10.3390/antiox10081306 – volume: 2013 start-page: 1 year: 2013 ident: B20 article-title: Therapeutic Effect of MG132 on the Aortic Oxidative Damage and Inflammatory Response in OVE26 Type 1 Diabetic Mice publication-title: Oxidative Med. Cell. Longev. doi: 10.1155/2013/879516 – volume: 133 start-page: 195 year: 2019 ident: B28 article-title: Trained Immunity and Diabetic Vascular Disease publication-title: Clin. Sci. (Lond) doi: 10.1042/CS20180905 – volume: 10 start-page: 1463 year: 2021 ident: B2 article-title: Nrf2 and Heme Oxygenase-1 Involvement in Atherosclerosis Related Oxidative Stress publication-title: Antioxidants doi: 10.3390/antiox10091463 – volume: 48 start-page: 187 year: 2021 ident: B11 article-title: Oxymatrine Attenuates Oxidized Low-density L-ipoprotein-induced HUVEC I-njury by I-nhibiting NLRP3 I-nflammasome-mediated P-yroptosis via the A-ctivation of the SIRT1/Nrf2 S-ignaling P-athway publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2021.5020 – volume: 173 start-page: 105868 ident: B32 article-title: Targeting the microRNAs in Exosome: A Potential Therapeutic Strategy for Alleviation of Diabetes-Related Cardiovascular Complication publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2021.105868 – volume: 25 start-page: 65 year: 2017 ident: B18 article-title: MicroRNA-142-5p Overexpression Inhibits Cell Growth and Induces Apoptosis by Regulating FOXO in Hepatocellular Carcinoma Cells publication-title: Oncol. Res. doi: 10.3727/096504016X14719078133366 – volume: 34 start-page: 205873842090904 year: 2020 ident: B17 article-title: miR-142-5p Regulates the Progression of Diabetic Retinopathy by Targeting IGF1 publication-title: Int. J. Immunopathol. Pharmacol. doi: 10.1177/2058738420909041 – volume: 10 start-page: 824165 year: 2022 ident: B26 article-title: The Molecular Pathways of Pyroptosis in Atherosclerosis publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2022.824165 – volume: 211 start-page: 69 year: 2010 ident: B10 article-title: Protective Effects of Magnesium Lithospermate B against Diabetic Atherosclerosis via Nrf2-ARE-NQO1 Transcriptional Pathway publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2010.01.035 – volume: 11 start-page: 3229 year: 2015 ident: B31 article-title: Upregulation of miR-142-5p in Atherosclerotic Plaques and Regulation of Oxidized Low-Density Lipoprotein-Induced Apoptosis in Macrophages publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2015.3191 – volume: 445 start-page: 105 year: 2018 ident: B15 article-title: Fenofibrate Ameliorates Diabetic Retinopathy by Modulating Nrf2 Signaling and NLRP3 Inflammasome Activation publication-title: Mol. Cell Biochem. doi: 10.1007/s11010-017-3256-x – volume: 15 start-page: 293 year: 2014 ident: B3 article-title: Jvenn: an Interactive Venn Diagram Viewer publication-title: BMC Bioinforma. doi: 10.1186/1471-2105-15-293 – volume: 125 start-page: 43 year: 2019 ident: B22 article-title: Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial Cells publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.118.314601 – volume: 548 start-page: 127 year: 2021 ident: B29 article-title: Melatonin Attenuates Restenosis after Vascular Injury in Diabetic Rats through Activation of the Nrf2 Signaling Pathway publication-title: Biochem. Biophysical Res. Commun. doi: 10.1016/j.bbrc.2021.02.070 – volume: 116 start-page: 281 year: 2004 ident: B4 article-title: MicroRNAs publication-title: Cell doi: 10.1016/s0092-8674(04)00045-5 – volume: 21 start-page: 77 year: 2021 ident: B21 article-title: Circulating Level of microRNA-142-5p Is a Potential Biomarker for Predicting In-Stent Restenosis: a Case-Control Study publication-title: BMC Cardiovasc Disord. doi: 10.1186/s12872-021-01893-y – volume: 46 start-page: D239 year: 2018 ident: B13 article-title: DIANA-TarBase V8: a Decade-Long Collection of Experimentally Supported miRNA-Gene Interactions publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkx1141 – volume: 12 start-page: 1476 year: 2021 ident: B12 article-title: Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles publication-title: Aging Dis. doi: 10.14336/AD.2021.0708 – volume: 20 start-page: 18 year: 2019 ident: B16 article-title: Prediction of Functional microRNA Targets by Integrative Modeling of microRNA Binding and Target Expression Data publication-title: Genome Biol. doi: 10.1186/s13059-019-1629-z – volume: 8 start-page: 733985 year: 2021 ident: B30 article-title: Mechanisms of Action of MiRNAs and LncRNAs in Extracellular Vesicle in Atherosclerosis publication-title: Front. Cardiovasc. Med. doi: 10.3389/fcvm.2021.733985 – volume: 575 start-page: 65 year: 2021 ident: B8 article-title: Exosomal Long Non-coding RNA LIPCAR Derived from oxLDL-Treated THP-1 Cells Regulates the Proliferation of Human Umbilical Vein Endothelial Cells and Human Vascular Smooth Muscle Cells publication-title: Biochem. Biophysical Res. Commun. doi: 10.1016/j.bbrc.2021.08.053 – volume: 224 start-page: 325 year: 2019 ident: B23 article-title: Exosomes Derived from Monocytes and from Endothelial Cells Mediate Monocyte and Endothelial Cell Activation under High D-Glucose Conditions publication-title: Immunobiology doi: 10.1016/j.imbio.2019.02.004 – volume: 10 start-page: 2663 year: 2021 ident: B24 article-title: Role of Extracellular Vesicles in Cell Death and Inflammation publication-title: Cells doi: 10.3390/cells10102663 – volume: 9 start-page: 1857 year: 2018 ident: B27 article-title: Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes publication-title: Front. Physiol. doi: 10.3389/fphys.2018.01857 – volume: 39 start-page: 3521 year: 2018 ident: B7 article-title: Monocyte and Haematopoietic Progenitor Reprogramming as Common Mechanism Underlying Chronic Inflammatory and Cardiovascular Diseases publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehx581 – volume: 13 start-page: 11363 ident: B33 article-title: Melatonin Attenuates Smoking-Induced Atherosclerosis by Activating the Nrf2 Pathway via NLRP3 Inflammasomes in Endothelial Cells publication-title: Aging doi: 10.18632/aging.202829 – volume: 37 start-page: 495 year: 2005 ident: B14 article-title: Combinatorial microRNA Target Predictions publication-title: Nat. Genet. doi: 10.1038/ng1536 – volume: 19 start-page: 92 year: 2009 ident: B5 article-title: Most Mammalian mRNAs Are Conserved Targets of microRNAs publication-title: Genome Res. doi: 10.1101/gr.082701.108 – volume: 200 start-page: 1677 year: 2021 ident: B1 article-title: The Prospective Ameliorative Role of Zinc Oxide Nanoparticles in STZ-Induced Diabetic Nephropathy in Rats: Mechanistic Targeting of Autophagy and Regulating Nrf2/TXNIP/NLRP3 Inflammasome Signaling publication-title: Biol. Trace Elem. Res. doi: 10.1007/s12011-021-02773-4 |
SSID | ssj0001257582 |
Score | 2.2414052 |
Snippet | Endothelial dysfunction is a key accessory to diabetic cardiovascular complications, and the regulatory role of the extracellular vesicles (EVs) from the... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 913791 |
SubjectTerms | Bioengineering and Biotechnology diabetes mellitus endothelial damage extracellular vesicles miR-142-5p monocytes |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1da9YwFA6yK70QN7_qnETwSqhr0nw03s3tnVNQRLaxu5JPLGzt2NuJ-yX-XU-S7qWviN542TYhh5yT5DnpkycIvaosY1RqW_IQj-TAolNqL-rSac2Nss5pE_c7Pn0WRyfs4xk_m131FTlhWR44d9wu0YZXtZVSaMukl1oL6iGJkME1iph0dA_WvFkylXdXAIY0NP_GhCxM7QbTDVEWk9I3itRJk3O2ECW9_j-BzN-5krPF5_ABuj-hRryXrd1Ed3y_he7NtAQfop97-MswRu4PFDxO_G4MgBRnyktn8enEOcUH-gImkbc4Ujzw-0xZL-MVHtY7DGN8sDejx4sfYEjc1k91Tv0y8efwB5g-uiu86F08unUeG9uHQktsbvABPH9P5uCL7mtJGCSgl4_QyeHieP-onG5dKC0TfCyhwxU3lHviKqcUFTZ4QjSnIVgAe0a7iuqooqac8FxayPeI11KT2lW2qVn9GG30Q--fIhyM8kzVPNRCM9I4JYJtAlPCVR7yGlmg6tYFrZ0kyePNGOctpCbRa23yWhu91mavFej1qspl1uP4W-F30a-rglFKO72AAGunAGv_FWAFenkbFS0MvdjxuvfD9bKl8YgTIFzCC_QkR8mqqRpwKWeSFUiuxc-aLetf-u5bkvdWALmapnn2P4zfRndjfySGpnqONsara78DKGo0L9KA-QXU7hzd priority: 102 providerName: Directory of Open Access Journals |
Title | A Potential Target for Diabetic Vascular Damage: High Glucose-Induced Monocyte Extracellular Vesicles Impair Endothelial Cells by Delivering miR-142-5p |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35615474 https://www.proquest.com/docview/2670065015 https://pubmed.ncbi.nlm.nih.gov/PMC9124888 https://doaj.org/article/1ab503c776ac47e7aa62e0107fd891b9 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqIqFyQHw3QCsjcUJKiR07jpFQVdotBakIoW7VW-TYDkTaJmU3Rd1fwt9lxsmuumjFgWMSW3E8Y8-byfMMIa8TKwRXxsaywiM5YHRi47M0dsbIUlvnTInxjtMv2clYfL6QFxtkUd5qmMDZWtcO60mNp5O9m5_zfVjw79HjBHv7tirrFjNecr6nWarwLPsdMEwKCxqcDmi_D7kANsl5_29zfc8tcjcFRCGFEiuGKuTzXwdC_-ZS3jJOxw_I_QFV0oNeDR6SDd88Ivdu5Rp8TH4f0K9th9wgaHgW-N8UACvtKTG1pecDJ5UemUvYZN5RpIDQjz2lPcYSH9Y7CntAa-edp6MbGAiG_UOfcz8L_Dr6CbaXekpHjcOjXRN82SE0mtFyTo_g-lcYDr2sv8VMgIN69YSMj0dnhyfxUJUhtiKTXcxMqWXJpWcucVrzzFaeMSN5VVkAg6VxCTeYZU27zEtlwR9k3ijDUpfYPBXpU7LZtI3fJrQqtRc6lVWaGcFyp7PK5pXQmUs8-D0qIslCBIUdUpZj5YxJAa4LCrAIAixQgEUvwIi8WXa56vN1_KvxB5TrsiGm2g432un3Yli5BXyvTFKrVGasUF4Zk3EPXqyqXK5ZqSPyaqEVBSxNnHjT-PZ6VnA8AgUImMmIPOu1ZPmqhZZFRK3oz8pYVp809Y-Q_lsDJMvz_Pl_93xBtnASAm1TvySb3fTa7wC06srdEJLYDcvmD1IMJnI |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Potential+Target+for+Diabetic+Vascular+Damage%3A+High+Glucose-Induced+Monocyte+Extracellular+Vesicles+Impair+Endothelial+Cells+by+Delivering+miR-142-5p&rft.jtitle=Frontiers+in+bioengineering+and+biotechnology&rft.au=Zhang%2C+Rui&rft.au=Niu%2C+Shuai&rft.au=Rong%2C+Zhihua&rft.au=Li%2C+Fengshi&rft.date=2022-05-09&rft.pub=Frontiers+Media+S.A&rft.eissn=2296-4185&rft.volume=10&rft_id=info:doi/10.3389%2Ffbioe.2022.913791&rft_id=info%3Apmid%2F35615474&rft.externalDocID=PMC9124888 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-4185&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-4185&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-4185&client=summon |